Forte Biosciences, Inc. (FBRX) Revenue History
Annual and quarterly revenue from 2015 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
FBRX Revenue Growth
FBRX Revenue Analysis (2015–2024)
As of May 8, 2026, Forte Biosciences, Inc. (FBRX) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q3 2025) recorded $0 in revenue.
Looking at the longer-term picture, FBRX's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $18.0 million in 2018.
When compared to Healthcare sector peers including ETON (+104.9% YoY), and TARS (+129.0% YoY). Compare FBRX vs ETON →
FBRX Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| FBRXCurrent | $0 | - | - | - | |
 ETON | $80M | +104.9% | +359.6% | -1.1% | |
 TARS | $451M | +129.0% | - | -15.7% |
FBRX Historical Revenue Data (2015–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $0 | - | $-39,000 | - | $-36,602,000 | - |
| 2023 | $0 | - | $-9,000 | - | $-32,486,000 | - |
| 2022 | $0 | - | $0 | - | $-13,896,000 | - |
| 2021 | $0 | - | $-36,000 | - | $-21,486,000 | - |
| 2020 | $0 | - | $-54,000 | - | $-14,225,000 | - |
| 2019 | $0 | -100.0% | $-11,000 | - | $-4,064,000 | - |
| 2018 | $18.0M | +43890.2% | $18.0M | 100.0% | $-45,853,000 | -254.2% |
| 2017 | $41K | -16.3% | $41K | 100.0% | $-37,629,000 | -91778.0% |
| 2016 | $49K | -3.9% | $49K | 100.0% | $-31,691,000 | -64675.5% |
| 2015 | $51K | - | $51K | 100.0% | $-22,954,000 | -45007.8% |
See FBRX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs FBRX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare FBRX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonFBRX — Frequently Asked Questions
Quick answers to the most common questions about buying FBRX stock.
Is FBRX's revenue growth accelerating or slowing?
FBRX TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is FBRX's long-term revenue growth rate?
Forte Biosciences, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is FBRX's revenue distributed by segment?
FBRX reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2015-2024 are available for download. Segment mix reveals concentration and diversification trends.